Procalcitonin Level and the High Risk of Mortality in 30 Days in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patient , Cases Series.

Clinical trial NCT05008016 · COMPLETED

Trial details

NCT number: NCT05008016
Sponsor: Mohammed VI University Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

the Relationship Between Procalcitonin and 30-day Mortality in COVID Patients

Start date: 2020-01-01
Primary completion: 2020-01-01
Enrollment: 582

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.